Foresight Diagnostics is an early-stage, venture-backed molecular diagnostics company developing non-invasive cancer detection technologies to improve patient lives. Their portfolio of cell-free DNA based liquid biopsy tests are rooted in novel methods from Stanford University, enabling earlier detection of smaller tumors for more personalized cancer treatment.
